{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/658e4b085b1cd50016929a67/66289cb66b51e80012c922b2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"To p(53) or not to p(53): interview with Dr. Mariam Nawas","description":"<p>What a delight to have Dr. Mariam Nawas of the University of Chicago join us for a round-up of her favorite abstracts from Tandem 2024! We also discussed her recent and controversial review \"<a href=\"https://ashpublications.org/bloodadvances/article-lookup/doi/10.1182/bloodadvances.2023010417\" rel=\"noopener noreferrer\" target=\"_blank\">Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML</a>\", which appeared in Blood Advances earlier this year. </p>","author_name":"Mohammad Alhomoud and Joshua Fein"}